On this page
Lacosamide
Active ingredient 10 prescription 24 with labelling
Overview
Source: NDC DirectoryIngredient name
LACOSAMIDE
Base moiety
LACOSAMIDE
RxNorm CUI
UNII
563KS2PQY5
Medication products
14
Brand names
5
Dosage forms
8
FAERS reports
36,995 · not a risk measure
- Lacosamide Powder, for Solution
- Lacosamide Powder
- lacosamide Capsule, Extended Release
- Lacosamide (CIP Process) Powder
- Vimpat lacosamide · Injection
- Vimpat lacosamide · Solution
- Lacosamide Injection
- Lacosamide Solution
- Lacosamide Tablet, Film Coated
- Lacosamide Tablet
- LACOSAMIDE Lacosamide · Injection, Solution
- Lacosamide Oral Solution Lacosamide · Solution
- MOTPOLY XR lacosamide · Capsule, Extended Release
- Vimpat lacosamide · Tablet, Film Coated
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Solution | 3 | Vimpat, Lacosamide, Lacosamide Oral Solution |
| Powder | 2 | Lacosamide, Lacosamide (CIP Process) |
| CAPSULE, Extended Release | 2 | lacosamide, MOTPOLY XR |
| Injection | 2 | Vimpat, Lacosamide |
| TABLET, Film Coated | 2 | Lacosamide, Vimpat |
| POWDER, For Solution | 1 | Lacosamide |
| Tablet | 1 | Lacosamide |
| INJECTION, Solution | 1 | LACOSAMIDE |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |